Hearts injected with Map4k4-siRNA-loaded GeRPs (n = 3/group) or PBS (n = 5–6/group) were procured at 3 or 7 days after infarction; normal hearts without infarction or surgery served as reference controls (n = 8). The gene discussed is MAP4K4; the disease is infarction.